There is a need to revamp education system | Prof Chandrakant Kokate
How should we revamp our pharma education to provide more emphasis on clinical and practical training, with a research oriented…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Revitalising pharmacy education
While there are good intentions, it is the implementation which threatens the viability of initiatives like the Pharm D course…
3rd LOC meeting of 70th IPC was held at PHD chamber of commerce, New Delhi
BR Sikri informed that in the 2nd IPCA meeting held at Mumbai with Dilip Shanghavi, most of the points were discussed with regards…
Panacea inks pact with Natco, Breckenridge for cancer drug
Natco has provided the technology for manufacturing Azacitidine to Panacea Biotec's Baddi facility
Lupin’s Nagpur plant gears for future growth
During a recent plant visit to Lupin’s Nagpur facility, Swati Rana in an interaction with
Rajiv Desai, Executive VP - Corporate…
India adopts proactive approach in adopting biosimilars to bring down cost
Introduction of new drugs in the form of biosimilars will bring in new drug delivery system. The Indian pharma companies are…
Behind all the hype and hoopla about biosimilars
Looking at the pipeline of biosimilars, India shall remain a major market for biosimilars. Dr Siddharth Dutta, Associate Vice…
Bayer, J&J’s heart drug Xarelto fails trial to widen use
The blockbuster clot prevention drug could not be shown to reduce the rate of dangerous blood clots in a certain group of…
Good medicines come in quality packages
In the third of a series of six articles, Organisation of Pharmaceutical Producers of India (OPPI) launches the Know Your Pill…
Pfizer, Astellas revise two cancer drug trial protocols to speed up results
Both trials are testing Xtandi in men with hormone-sensitive prostate cancer